CLNNMICRO

Clene Inc.

HealthcareBiotechnology
$7.39
$0.00(+3.21%)
52W$2.28
$13.50
Updated May 7, 12:00 AM
RSI58
RS Rating55/99
Beta1.97
Volatility119%
F-Score1/9
Mkt Cap$74M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Clene Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 55), indicating performance broadly in line with the market. Earnings growth of 52% provides fundamental context to the price action. However, price is extended 25% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
55
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
1.97
vs S&P 500
HIGH BETA
52W Position
46%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$5.91
50 SMA > 100 SMA$5.58
100 SMA > 150 SMA$6.67
150 SMA > 200 SMA$6.27

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$6.44+14.81%ABOVE
50 SMA$5.91+25.10%ABOVE
100 SMA$5.58+32.54%ABOVE
150 SMA$6.67+10.79%ABOVE
200 SMA$6.27+17.84%ABOVE

Price Performance

1D+3.2%
1W+20.0%
1M+18.1%
3M+66.1%
6M-24.5%
YTD+28.1%
1Y+189.8%
3Y-26.6%
52-Week Trading Range46% from low
$7.39
52W Low$2.28
52W High$13.50

Technical Indicators

RSI (14)NEUTRAL
58.3
305070
VCP ScoreCOOL
1/10
Base depth: 63.7%

Risk Profile

Beta
1.97
52W Vol
119%
ATR
$0.49
Max DD (1Y)
-69%

Volume Analysis

Today
435.3K
50D Avg
557.7K
Vol Ratio
0.78x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25+95%
$-0.09
Q2'25+26%
$-0.78
Q3'25+30%
$-0.85
Q4'25+52%
$-0.93
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:-0.59%
3 Years:-24.94%
TTM:-41.52%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+55.62%

Stock Price CAGR

10 Years:-27.91%
5 Years:-47.42%
3 Years:-26.62%
1 Year:+189.80%

Return on Equity

10Y Avg:-561.7%
5Y Avg:-715.6%
3Y Avg:-1166.9%
Last Year:

Key Metrics

Market Cap$74M
Gross Margin78.5%
Net Margin-130.9%
Piotroski F-Score1/9

Frequently Asked Questions

Is CLNN in an uptrend right now?

CLNN has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is CLNN overbought or oversold?

CLNN's RSI (14) is 58. The stock is in neutral territory, neither overbought nor oversold.

Is CLNN outperforming the market?

CLNN has a Relative Strength (RS) Rating of 55 out of 99. CLNN is performing about average compared to the market.

Where is CLNN in its 52-week range?

CLNN is trading at $7.39, which is 55% of its 52-week high ($13.50) and 46% above its 52-week low ($2.28).

How volatile is CLNN?

CLNN has a Beta of 1.97 and 52-week volatility of 119%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.